Becton Dickinson Intraosseous Needle Injury and Wrongful Death Lawsuit Lawyers

FDA Identifies Recall of Certain BD Intraosseous Vascular Access System Needle Sets as Most Serious Type After Manufacturing Problems May Delay Lifesaving Emergency Treatment.

What Parker Waichman LLP Found

• Intraosseous needle sets are used to deliver fluids and medications quickly into a patient’s bone when a regular IV live cannot be used quickly enough.
• The issue is that, after the needle is inserted, the obturator, also known as the stylet, may become locked in place and cannot be removed.
• The FDA identified this as its most serious type of medical device recall because continued use may cause serious injury or death.
• BD reported 45 serious injuries and four deaths associated with the issue as of July 22, 2026.
• Affected lots were manufactured with out-of-tolerance dimensions that can contribute to locking between the obturator and needle hub.
• The greatest risk involves critically ill patients, including cardiac arrest and severe trauma patients, because a device problem may delay lifesaving treatment.
• A potential lawsuit should investigate the exact product and lot used, the length of any treatment delay, subsequent injuries, and medical evidence connecting the delay to the patient’s outcome.

Some Becton Dickinson intraosseous needle sets are being removed from healthcare facilities and other locations where the affected devices are used or sold after reports of a manufacturing problem that can affect how they work. The U.S. Food and Drug Administration has called this recall of certain BD Intraosseous Vascular Access System Needle Sets the most serious type, warning that continued use could lead to serious injury or death.

This issue is especially worrying because intraosseous (IO) access is often needed when time is critical. These devices are used when regular IV access is hard or impossible in very sick or badly injured patients. If the needle system fails, medical staff may need to stop using it and quickly find another way to give medications, fluids, or blood. In emergencies like cardiac arrest, major trauma, or shock, even a short delay in treatment can have serious effects.

According to the FDA, Becton Dickinson reported 45 serious injuries and four deaths associated with the issue as of July 22, 2026. The affected lots were manufactured with dimensions outside specified tolerances, and users have reported difficulty removing the obturator, also called the stylet, after insertion. The company initiated a nationwide recall of specified lots and instructed affected customers to discontinue their use.

Patients or families who have faced serious injuries or a death after problems with one of these devices may wonder if a faulty product played a role. Answering this often means closely reviewing the device used, its lot number, emergency medical records, medication times, hospital and EMS records, manufacturing details, and what happened during treatment.

What Is the BD Intraosseous Vascular Access System?

The BD Intraosseous Vascular Access System is intended to establish vascular access through bone when traditional intravenous access is difficult or impossible. According to the FDA, the system can be used in the proximal tibia, distal tibia, and proximal humerus in adult and pediatric patients and in the distal femur in pediatric patients. It is intended for emergent, urgent, or otherwise medically necessary vascular access for periods of up to 24 hours.

Intraosseous access works because the interior of certain bones contains a vascular network capable of rapidly absorbing medications and fluids into the circulation. During an emergency, medical professionals can place an IO needle through the outer bone and into this vascular space. Once properly established, the line may allow critical medications, intravenous fluids, and other therapies to be administered when clinicians cannot quickly establish a conventional IV.

This is why reliability is so important. IO access is often used when a patient is already unstable. Emergency doctors, paramedics, nurses, and other clinicians may be treating cardiac arrest, severe bleeding, major trauma, dehydration, or other situations where fast access to veins is critical.

A device malfunction in an ordinary clinical situation can be troublesome. cA device malfunction in a regular medical situation can cause problems. But if a device fails during an emergency when quick vascular access is needed, it can be much more serious because there may be only a short time to prevent lasting harm or death.

According to the FDA and the company’s recall announcement, this dimensional problem can contribute to difficulty removing the obturator after the needle has been placed. The obturator, sometimes referred to as a stylet, is part of the needle assembly used during insertion. After placement, the clinician must remove the obturator so that the intraosseous catheter can be used for treatment. If the components rotate and lock together, the clinician may be unable to remove the obturator normally.

The FDA explains that the problem may occur when a user pulls back on the drill during insertion, does not withdraw the powered driver straight back, rotates the obturator, or attempts to unscrew it. In affected products with out-of-tolerance dimensions, those movements can permit rotation and locking at the obturator-needle hub interface.

This is significant because clinicians normally must be able to rely upon medical devices functioning within their prescribed dimensional specifications during foreseeable clinical use. Emergency medicine is inherently stressful, fast-moving, and sometimes performed under difficult conditions. Medical equipment intended for these environments should account for reasonably foreseeable ways in which clinicians handle the device.

When an IO needle cannot immediately provide usable vascular access, the medical team may need to retrieve another needle and attempt another IO placement or turn to peripheral or central venous access. Those additional steps take time while the underlying medical emergency continues.

How Do I Know If a BD Intraosseous Needle May Have Been Used?

Many patients and families may not know that an intraosseous, or “IO,” needle was used during emergency treatment. These devices are often used during cardiac arrest, severe trauma, shock, or other medical emergencies when a patient may be unconscious or when healthcare providers cannot quickly establish a traditional IV.

You or a family member may have been treated with an intraosseous needle if:

• Emergency medical personnel had difficulty establishing an IV or obtaining vascular access;
• Paramedics or hospital staff placed a needle into a bone, commonly in the leg or upper arm/shoulder area;
• Medical records refer to an “IO,” “intraosseous access,” “IO line,” “tibial IO,” “humeral IO,” “powered IO,” “stylet,” or “obturator”;
• Records describe an unsuccessful or repeated attempt to establish intraosseous access;
• Clinicians experienced difficulty removing a stylet or obturator after inserting an IO needle;
• A second IO needle or another form of vascular access had to be established before medications, fluids, or other emergency treatment could be administered; or
• There was an unexplained delay in administering emergency medications or treatment while vascular access was being established.

Why Can Difficulty Removing the Obturator Become Life-Threatening?

The central danger associated with this recall is not simply that a component becomes difficult to remove. The larger problem is what can happen during the time required to recognize the malfunction, abandon the device, obtain replacement equipment, and establish another vascular access route.

For a patient experiencing cardiac arrest, medications may need to be administered according to tightly coordinated resuscitation protocols. For someone who has sustained severe trauma and blood loss, clinicians may need rapid access to administer fluids, medications, or other therapy. A patient in profound shock may similarly require immediate vascular access.

If an IO device fails during this process, treatment may be delayed while clinicians attempt additional access.

The FDA specifically identifies critically ill patients requiring urgent vascular access, including patients experiencing out-of-hospital cardiac arrest and severe trauma, as those at greatest risk. The agency warns that a delay in initiating therapy can result in serious injury or death.

The medical consequences of delayed therapy vary depending on the patient’s underlying emergency. Possible consequences can include prolonged cardiac arrest, inadequate circulation, worsening shock, extended oxygen deprivation, neurological injury, organ damage, or death. Whether a recalled device contributed to any particular injury requires individualized medical and factual analysis rather than an assumption based solely on the presence of the recalled product.

Which BD Intraosseous Needle Sets Are Affected?

The FDA’s recall information identifies five needle kit configurations included among the affected products:

• Needle Kit for Powered Driver 15mm x 15Ga, Catalog No. D015151NK, UDI-DI 00801741163586
• Needle Kit for Powered Driver 25mm x 15Ga, Catalog No. D015251NK, UDI-DI 00801741163678
• Needle Kit for Powered Driver 35mm x 15Ga, Catalog No. D015351NK, UDI-DI 00801741163593
• Needle Kit for Powered Driver 45mm x 15Ga, Catalog No. D015451NK, UDI-DI 00801741163609
• Needle Kit for Powered Driver 55mm x 15Ga, Catalog No. D015551NK, UDI-DI 00801741163616

The recall applies to specified lots rather than necessarily every needle set bearing those catalog numbers. BD stated that affected lots were manufactured with out-of-tolerance dimensions and were distributed between September 30, 2024, and June 12, 2026. The company’s notice also states that the recall does not affect the BD Intraosseous Powered Driver itself.

For patients, identifying the precise needle set may not be simple. A person undergoing emergency resuscitation is unlikely to know which brand, catalog number, or lot number was used. That information may instead appear in hospital supply records, EMS records, procedure notes, device logs, purchasing records, inventory documentation, or records maintained by the healthcare facility.

Injuries That May Result When Emergency Treatment Is Delayed

The injuries potentially associated with an IO access failure depend substantially on why the patient required emergency vascular access in the first place. Someone experiencing cardiac arrest faces different physiological risks than a patient experiencing severe hemorrhage after a collision, but both situations can involve extremely narrow treatment windows.

A prolonged interruption in circulation or oxygen delivery can potentially produce hypoxic-ischemic brain injury. Depending on the severity and duration, a patient may experience cognitive impairment, memory problems, motor deficits, seizures, impaired speech, difficulty swallowing, loss of independence, or a need for lifelong medical and personal care.

Patients suffering from severe trauma can deteriorate rapidly if medications, fluids, or blood products cannot be administered when clinically needed. Worsening shock can reduce blood flow to the brain, kidneys, liver, heart, and other organs. Severe cases may result in permanent organ injury, neurological impairment, prolonged hospitalization, or death.

A lawsuit must connect the alleged device failure to the resulting harm using medical evidence. The legal question is generally not whether the patient was already dangerously ill. Instead, the investigation may ask whether a defective device caused an additional treatment delay and whether that delay materially worsened an injury that otherwise could have been prevented or reduced.

Wrongful Death Claims Involving These Recalled Medical Devices

Four deaths had been reported in association with this issue as of July 22, 2026. Families who believe an affected intraosseous needle contributed to a death may be able to investigate a wrongful death and product liability claim.

Wrongful death laws differ substantially across states. Depending on the applicable jurisdiction, recoverable damages may include funeral and burial costs, certain medical expenses, lost financial support, lost services, and damages related to the loss suffered by qualifying surviving family members. Some jurisdictions also recognize separate survival claims for losses experienced by the deceased person between injury and death.

Causation is likely to be one of the central issues in these cases because many people receiving emergency IO access are already experiencing life-threatening medical conditions. Attorneys may need to determine whether the underlying cardiac arrest, trauma, or illness would probably have resulted in the same outcome regardless of the device problem or whether the treatment delay materially reduced the patient’s chances of survival or recovery.

This inquiry can require analysis of resuscitation records, EMS run sheets, hospital code records, medication administration logs, laboratory findings, imaging, neurological evaluations, and testimony from clinicians involved in the emergency.

BD Intraosseous Needle Set Recall Lawsuit FAQs

Can I File a Lawsuit If a Recalled BD Intraosseous Needle Was Used During My Treatment?

Possibly. The fact that a recalled device was used does not automatically establish a legal claim, but a lawsuit may warrant investigation if the needle malfunctioned and caused a delay that resulted in additional injury. Attorneys would typically determine whether the specific product and lot were recalled, whether clinicians experienced difficulty removing the obturator, how long vascular access was delayed, and whether that delay affected the patient’s medical outcome. Medical records, EMS documentation, device identification information, and hospital inventory records may all become important evidence. The applicable product liability law will depend on the jurisdiction and the circumstances surrounding the patient’s injury.

What If I Do Not Know Which Needle or Lot Number Was Used?

Many patients will not know this information because IO devices are often placed during unconsciousness, cardiac arrest, major trauma, or another emergency. The absence of a lot number in a patient’s possession does not necessarily end the investigation. Hospital purchasing records, ambulance inventory documents, supply records, procedure notes, invoices, and device tracking information may help identify the product that was available when treatment occurred. A legal investigation can also examine the dates during which recalled lots were distributed and compare that information with the patient’s treatment date and the healthcare facility’s inventory.

What Injuries Could Potentially Support a Lawsuit?

A potential case generally requires actual injury caused or worsened by the alleged device problem. Examples could include neurological damage following prolonged oxygen deprivation, worsening shock, organ injury, extended hospitalization, permanent disability, or death. The nature of the patient’s original medical emergency must also be considered. Because IO devices frequently are used in critically ill patients, medical evidence must distinguish injuries caused by the underlying emergency from harm that may have resulted from delayed treatment. This often makes causation one of the most medically and legally significant parts of a recalled IO needle lawsuit.

Can a Family File a Wrongful Death Lawsuit?

A wrongful death claim may be possible if evidence establishes that a defective recalled needle caused or materially contributed to treatment delay and that the delay contributed to the patient’s death. Wrongful death statutes differ from state to state regarding who may file, available damages, and filing deadlines. Medical evidence is likely to be especially important because patients receiving emergency IO access are already facing serious medical conditions. Attorneys may examine resuscitation timelines, medication administration, unsuccessful vascular access attempts, subsequent access placement, and the patient’s condition before and after the alleged device malfunction.

How Long Do I Have to File a BD Intraosseous Needle Lawsuit?

Deadlines depend on state law and the circumstances of the claim. Product liability and wrongful death statutes of limitation can vary significantly, and additional rules may determine when the filing period begins. Claims involving hospitals, governmental emergency medical services, or other public entities can potentially involve separate notice requirements with much shorter deadlines. Families should not assume that the date of an FDA recall determines the filing deadline. Prompt investigation can also help preserve medical records, inventory information, lot records, and other evidence needed to establish which device was used.

Contact Parker Waichman LLP About Your BD Intraosseous Needle Set Injury or Death Claim

When an emergency medical device fails, the patient affected may have been entirely unable to protect himself or herself from the consequences. A person experiencing cardiac arrest, severe trauma, shock, or another critical medical emergency depends on medical equipment functioning when seconds matter. When a recalled intraosseous needle allegedly interferes with vascular access and delays necessary therapy, determining exactly what happened may require immediate examination of medical records, device information, hospital inventory records, treatment timelines, and other evidence.

Parker Waichman LLP represents individuals and families throughout the United States in serious personal injury, wrongful death, and defective medical device matters. If you or a family member suffered a serious injury after a BD Intraosseous Vascular Access System Needle Set malfunctioned, or if a loved one died after emergency treatment was allegedly delayed because of one of these devices, the firm can review the circumstances and determine whether there may be a basis for pursuing compensation.

Call Parker Waichman LLP at 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation about a potential BD Intraosseous Needle Set recall lawsuit. There is no charge to learn about your legal options to monetary compensation and filing your product liability claim. Regardless of your location or where the injury occurred, our nationwide product injury law firm is ready to assist you.